Orad: are NIS 102.8 million of receivables and accrued revenue a growth engine or a working-capital trap
The right way to read Orad’s receivables line is not to ask first whether the debt is bad, but to ask how much of it is already a plain trade balance and how much still depends on contract completion, billing and supplier-credit support. In 2025 the customer-versus-supplier credit gap widened back to 77 days, which makes this line look more like a financing test than a routine balance-sheet item.
The main article made a simple point: Orad ended 2025 with a better backlog and a stronger solar contribution, but the real bottleneck was still working capital. This follow-up isolates the exact line where that bottleneck shows up, NIS 102.8 million of receivables and accrued revenue, because that is where the distinction sits between growth that funds itself and growth that leans on the balance sheet.
This is not primarily a bad-debt story. At the end of 2025 only about NIS 7.7 million of customer balances were older than 180 days, and the expected credit-loss allowance was NIS 1.8 million, unchanged from year-end 2024. Anyone looking for a classic collections collapse does not really see it in the numbers.
The problem sits elsewhere. Not all of the NIS 102.8 million is a plain open invoice balance that has already been billed and is simply waiting to be paid. NIS 25.7 million is classified as accrued revenue, which means part of the line also depends on project progress and on the company’s ability to complete contracts at the cost assumptions embedded in the current accounting. Add average customer credit of 164 days against supplier credit of only 87 days, and the picture becomes much sharper: Orad is not just carrying slow-paying customers. It is carrying a growth model that requires it to finance a large credit gap from its own cash and facilities.
What Is Actually Inside NIS 102.8 Million
The headline number creates the impression of one line, but in practice there are three very different sub-stories inside it:
| Component | Year-end 2025 | Share of the line | Why it matters |
|---|---|---|---|
| Open receivables | NIS 76.3 million | 74.2% | This is the classic trade balance, and the test is straightforward collection |
| Accrued revenue | NIS 25.7 million | 25.0% | This is no longer only a collection test, but also an execution, delivery and cost-estimate test |
| Checks for collection | NIS 2.6 million | 2.5% | Small relative piece, not the core issue |
The key datapoint here is not the absolute size but the mix. A quarter of the line sits in accrued revenue. That means even if there is no obvious deterioration in problematic debt, part of this asset still has more stations to pass before it becomes cash: contract completion, progress approval and, in some cases, billing.
That is why the quality question cannot stop at aging. If the full NIS 102.8 million were plain open trade debt, the discussion would mostly be about customers, collection discipline and the allowance. Once NIS 25.7 million is classified as accrued revenue, the quality of the line also depends on the quality of accounting recognition and on whether projects continue to converge to the cost assumptions management is using today.
The relatively comforting point is that the far-end aging bucket is still limited. The company reports only NIS 7.7 million above 180 days, with an allowance of NIS 1.8 million against it. That is not the profile of a line that has already broken. But it is also not a line that should be read as cash-in-transit. For this balance to turn into cash, it is not enough that customers pay. The accrued-revenue portion also has to keep progressing without disruption.
The Real Issue: The Credit Gap Opened Again
This line should not be read on its own. It has to be read against the other side of working capital, suppliers and subcontractors. And this is where the non-obvious point appears: customer credit did not worsen versus 2024, but supplier credit did get shorter.
| Year | Customer credit days | Supplier credit days | Credit gap |
|---|---|---|---|
| 2023 | 156 | 79 | 77 days |
| 2024 | 164 | 102 | 62 days |
| 2025 | 164 | 87 | 77 days |
That is the heart of the thesis. Customers did not become slower than they were in 2024, but suppliers financed less of the business. The result is that the credit gap widened back from 62 days to 77 days. Put differently, Orad did not enter 2026 with a new collections problem. It entered 2026 with less natural financing from the operating chain around it.
The company’s own liquidity discussion points in the same direction. In the board report it explains that operating cash flow declined mainly because supplier balances fell by NIS 0.6 million in 2025, versus a NIS 10.0 million increase in the prior year. That matters because it says the cash-pressure story of 2025 was not only about customers. It was also about the fact that suppliers were no longer carrying the same share of funding they carried in 2024.
Inventory does not look like the bottleneck. The company reports only 48 inventory days at the end of 2025. So this is not a stock sitting in warehouses story. It is a projects, customers, subcontractors and payment-timing story. That is why the NIS 102.8 million line should be read as a financing junction, not as an isolated collection datapoint.
The Cash Bridge: From Profit To Cash On Hand
Anyone who stops at NIS 15.1 million of net profit misses the critical layer. The cash-flow statement shows that the business did generate cash, but much less than the bottom line suggests, and certainly much less than remained after the year’s real commitments.
| Cash bridge | Calculation | Result |
|---|---|---|
| Ongoing cash generation | Operating cash flow of NIS 18.0 million less reported CAPEX of NIS 0.6 million | About NIS 17.4 million |
| All-in cash picture | Operating cash flow of NIS 18.0 million less CAPEX of NIS 0.6 million, less interest paid of NIS 2.1 million, less lease-principal repayment of NIS 10.3 million, and less net bank-debt repayment of NIS 7.0 million | About negative NIS 2.0 million |
The gap between the two bridges explains why the receivables line matters so much. At the underlying operating level, Orad still knows how to produce cash. But once real uses are included, leases, interest and net bank-debt reduction, the picture becomes much tighter. Year-end cash stood at only NIS 2.7 million, down from NIS 4.2 million a year earlier.
That is why NIS 102.8 million of receivables and accrued revenue is not a theoretical issue. When the cash balance itself is low, every extra week in collections and every small delay in billing or delivery becomes far more visible. The more the balance sheet has to finance the credit gap, the lower the model’s tolerance for execution mistakes.
This Is Not Only About Collection, It Is Also About Contract Accounting
This is where the auditor’s highlighted signal matters. Estimated future contract costs were flagged as a key audit matter. That is not throwaway technical wording. It is a clear statement that part of project revenue depends on management’s estimate of what still needs to be spent in order to complete performance obligations.
The working-capital implication is twofold. On one hand, accrued revenue is not automatically a red flag. In a project company it is a normal part of the model. On the other hand, it is not the same thing as cash on the way. As long as part of the line is recognized over time, the quality of conversion to cash depends not only on whether the customer will pay, but also on whether the project is completed on schedule, without material cost overruns and without a meaningful change in the completion estimate.
This is exactly where the article’s title gets a more nuanced answer. The line is a growth engine only if accounting recognition and operating execution continue to converge into cash. If they do not, it can become a working-capital trap even without visible insolvency and even without a sharp jump in bad debt.
It is important to keep the balance fair. There is no hard numerical signal in year-end 2025 showing that customers have stopped paying or that the allowance has lost touch with reality. On the contrary, the company states that beyond the balances above 180 days, it does not have material customer balances in arrears. So the intelligent counter thesis exists: this may simply be a normal credit structure for a project company serving institutional and corporate clients, not a deep asset-quality problem.
But the counter thesis does not solve the funding question. Even if customers are good, and even if accrued revenue ultimately becomes cash, the path still consumes credit, guarantees and balance-sheet patience. In 2025 Orad enjoyed better profit, but not a larger cash cushion.
What This Line Really Says About 2026
The right read of year-end 2025 is not “Orad has a collection crisis,” but it is also not “everything is fine because the allowance is low.” The NIS 102.8 million balance says something sharper: Orad is growing through a model in which part of revenue is recognized before cash is in the bank, while supplier credit has stopped being as supportive as it was in 2024.
That leads to three checkpoints for the next stage:
- Conversion of accrued revenue into cash. If accrued revenue remains elevated even as projects move forward, that would mean the line is still inflating faster than it is unwinding into cash.
- Repair of the credit gap. Even without an improvement in customer days, it would already help if supplier days stop eroding.
- A cash balance that rises without bringing the banks back to the center of the story. If future reports still show low cash and more profit staying on the balance sheet, the market will read the growth at a lower quality.
The conclusion is fairly sharp. NIS 102.8 million of receivables and accrued revenue is not yet a bad-debt warning light, but it is already a funding-model warning light. It can support growth, but right now it does so at the price of a tighter balance sheet and heavier dependence on precise execution and on supplier credit not getting tighter again.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.